Skip to main content
. 2023 Sep 28;24(1):1522. doi: 10.4102/sajhivmed.v24i1.1522

TABLE 7.

Management of HBV in the exposed individual.

Hepatitis B status of source individual HBV vaccination status of exposed individual
Not vaccinated Fully vaccinated, documented responder (HBsAb titre ≥ 10 mIU/mL) Vaccinated, documented non-responder (HBsAb titre < 10 mIU/mL) Vaccinated, HBsAb status unknown
HbsAg positive, or HbsAg unknown
  • Give HBIG, IM, 500 IU

  • No action

  • Give HBIG, IM, 500 IU, then repeat after 1 month

Test exposed individual’s HBsAb:
  • Initiate hepatitis B vaccine series

  • Re-initiate hepatitis B vaccine series (if not previously attempted)

  • If positive and titre ≥ 10 mIU/mL, no action

  • If titre < 10 mIU/mL, give HBIG and hepatitis B vaccine booster, and recheck titre in one month

HbsAg negative Initiate hepatitis B vaccine series
  • No action

  • Re-initiate hepatitis B vaccine series (if not previously been attempted)

Test exposed individual’s HBsAb:
  • If positive and titre ≥ 10 mIU/mL, no action

  • If < 10 mIU/mL, give hepatitis B vaccine booster and repeat titre after 1 month

Source: Adapted from National Guidelines for the Management of Viral Hepatitis. National Department of Health; c2019 [cited 2023 Jul 13]. Available from: https://knowledgehub.health.gov.za

HbsAg, hepatitis B surface antigen; HBIG, hepatitis B immunoglobulin; IM, intra-muscular; HBsAb, Hepatitis B surface antibodies.

HBIG and first dose of vaccine should be administered simultaneously, at different sites.

If testing for HBsAb will be delayed for > 24 h, treat as non-responder.